Nitika Mor | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Nitika Mor | Drug Discovery and Development | Best Researcher Award

Dr. Nitika Mor, Baba Mastnath University, Asthal Bohar, Rohtak (HR), India

Dr. Nitika Mor is an accomplished Assistant Professor of Chemistry at Baba Mastnath University, Rohtak, with a Ph.D. in Pharmaceutical Chemistry from Kurukshetra University. Her research focuses on drug delivery systems, traditional medicinal formulations, and molecular docking. She has published 14 research papers, authored a book chapter, holds two patent publications (one granted), and has received multiple awards including the UGC-CSIR JRF/SRF and Best Poster Award. With technical expertise in synthesis, biological assays, and in-silico studies, Dr. Mor is a dynamic contributor to pharmaceutical research and innovation.

Publication Profile

Google Scholar

Education

Dr. Nitika Mor is a dedicated researcher with a Ph.D. in Chemistry from Kurukshetra University (2017–2022), where she focused her thesis on the Design, Characterization, and In-Vitro Studies of Sustained Release Delivery Systems for Curcumin under the guidance of Dr. Neera Raghav. 🎓 She holds an M.Sc. in Organic Chemistry (2013–2015) from Hindu College, Sonipat, affiliated with Maharishi Dayanand University, Rohtak. 🧪 Her academic journey began with a B.Sc. in Physics, Chemistry, and Mathematics (2010–2013) from Hindu Girls College, Sonipat. 📚 Dr. Mor’s educational background reflects a strong foundation in science and innovative pharmaceutical research.

Experience

Dr. Nitika Mor is currently serving as an Assistant Professor in the Department of Chemistry at Baba Mastnath University, Rohtak, since February 1, 2023. 🏛️ With her strong academic foundation and research expertise in pharmaceutical and organic chemistry, she brings innovative teaching methods and deep subject knowledge to the classroom. 🧪 Her role involves mentoring students, delivering engaging lectures, and contributing to the academic growth of the department. 📚 Dr. Mor’s commitment to education and passion for chemistry make her a valuable asset to the university’s faculty. ✨ She continues to inspire budding scientists through her teaching and guidance.

Awards

Dr. Nitika Mor has received several prestigious awards and fellowships in recognition of her academic excellence and research potential. She qualified the UGC-CSIR JRF (Chemical Sciences) in June 2016 with an impressive All India Rank of 65. 🇮🇳 She was awarded the Junior Research Fellowship (JRF) from October 2017 to September 2019, followed by the Senior Research Fellowship (SRF) from October 2019 to March 2022 by UGC-CSIR India to support her Ph.D. journey. 🔬 In 2018, she received the Best Poster Presentation Award at the 9th National Conference on RACES-2018 held at MMM College, Patiala, Punjab.

Research Focus

Dr. Nitika Mor specializes in pharmaceutical and biomedical sciences, with a strong research focus on natural polymer-based oral drug delivery systems. Her work emphasizes the use of biopolymers like cellulose, pectin, carrageenan, and alginate for sustained release formulations, particularly for curcumin. She explores modifications of polysaccharides and curcumin derivatives to improve bioavailability, pharmacokinetics, and therapeutic efficacy. Her contributions also span phytochemistry, investigating medicinal plants like Ashwagandha and Garlic for their pharmacological benefits. Dr. Mor integrates green chemistry, molecular modeling, and clinical insights into her innovative drug delivery strategies.

Publication Top Notes

Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems

Some cetyltrimethylammonium bromide modified polysaccharide supports as sustained release systems for curcumin

Design and development of carboxymethylcellulose ester of curcumin as sustained release delivery system in liver

Synthesis of propynyloxy substituted some novel aurones as potent cathepsin B inhibitors

Alginate hydrogels: Sustained release system to analyze the effect of traditional excipients on curcumin availability

Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers

In-vitro simulation of modified-alginate ester as sustained release delivery system for curcumin

Curcumin, the panacea: A review on advancement to solve pharmaco-kinetic problems.

A review: Phytochemicals and bioactivities of Ashwagandha (Withania somnifera).

Charbel Fadel | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Charbel Fadel | Pharmacology | Best Researcher Award

Dr. Charbel Fadel, University of Pisa, Italy

Dr. Charbel Fadel is a renowned researcher in Veterinary Pharmacology with a PhD from the University of Sassari, Italy. He specializes in pharmacotherapy, quality control, and pharmacokinetics. Currently, Dr. Fadel is a Research Fellow at the University of Pisa, Italy, overseeing pharmacology lab operations and conducting animal studies. With a rich background in veterinary medicine, he has contributed to numerous scientific publications and presented at prestigious international conferences. Dr. Fadel’s work is focused on drug disposition, antimicrobial resistance, and improving veterinary pharmacology practices globally. He holds multiple honors and continues to impact veterinary science.

Publication Profile

Scopus

Education

Dr. Charbel Fadel is a distinguished veterinarian with extensive academic qualifications. He earned his Ph.D. in Veterinary Pharmacology, Pharmacotherapy, and Quality Control from the University of Sassari, Italy, in October 2023. Prior to this, he completed a Master’s degree in Veterinary Medicine, specializing in Small Animals’ Medicine, at L’Université Libanaise, Lebanon, in October 2020. His expertise in veterinary pharmacology and small animal care, combined with a passion for enhancing animal health, defines his professional journey.

Experience

Dr. Charbel Fadel has a rich professional background in veterinary medicine. Currently, he serves as a Research Fellow in Veterinary Pharmacology at the University of Pisa, Italy, where he oversees lab operations, manages pharmacokinetic studies, and collaborates with international teams to refine pharmacotherapy strategies. Before this, he was the Project and Operations Manager at IVet Medical in Beirut, Lebanon. In this role, he provided expert guidance to veterinarians on the use of biomedical machines, biological tests, and surgical instruments, while also managing the procurement and evaluation of medical supplies.

Awards

Dr. Charbel Fadel has earned numerous honors throughout his career. He has been an active reviewer for the Journal of Veterinary Pharmacology and Therapeutics since 2023 and was awarded the “Cultore della Materia” honor by the University of Pisa in January 2024 for his work as a Subject Specialist/Adjunct Lecturer. He received second runner-up for the 2023 JVPT Paper Award from Wiley Publishers, and his article on robenacoxib pharmacokinetics was recognized as the most cited in 2022-2023. Dr. Fadel also contributed to the “Rocinate Program” and completed several veterinary training programs in Russia.

Research Focus

Dr. Charbel Fadel’s research focus lies in veterinary pharmacology, particularly in the comparative pharmacokinetics of various drugs in livestock species like sheep and goats. His studies, including those on metronidazole and omeprazole, aim to enhance the understanding of drug absorption, distribution, metabolism, and excretion in these animals. This research is crucial for optimizing veterinary care and ensuring effective medication dosages in different animal species. Dr. Fadel’s work supports the development of more tailored and efficient treatment protocols for livestock, contributing to both animal health and agricultural practices.

Publication Top Notes

Comparative pharmacokinetic evaluation of metronidazole in sheep and goats

Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats

Minglong Yan | Drug Discovery and Development | Young Scientist Award

Published on by Top Pharmaceutical

Minglong Yan | Drug Discovery and Development | Young Scientist Award

Mr. Minglong Yan, Chinese Academy of Science, China

Mr. Minglong Yan holds advanced degrees in his field, with a distinguished academic and professional background in scientific research and innovation. He has completed multiple research projects, contributed to numerous indexed journal publications, and holds editorial appointments in reputable journals. With a strong citation index in SCI and Scopus, he is actively engaged in industry-sponsored projects, collaborative studies, and has authored several ISBN-registered books 📚. His expertise spans diverse research areas, contributing significantly to scientific advancement and innovation, including patents published or in process. Mr. Yan is also a member of esteemed professional organizations, fostering academic excellence globally 🌐.

Publication Profile

orcid

Education

Mr. Minglong Yan 🎓 holds advanced degrees in engineering and materials science, with a strong foundation in innovative research and development. With over a decade of professional experience, he has contributed significantly to the fields of advanced materials and nanotechnology. 🧪 His work has been recognized in peer-reviewed journals and international conferences. As a dedicated academic, he has mentored numerous students and collaborated on global research initiatives. 🌏 Mr. Yan’s achievements include multiple research grants and awards that highlight his impactful contributions to science and technology. 🔬 His commitment to excellence continues to inspire innovation and academic advancement.

Experience

Mr. Minglong Yan 🤝 has built strong interdisciplinary collaborations with researchers from institutions across various countries, fostering global scientific exchange and innovation. 🌐 His collaborative efforts have led to numerous joint publications, international workshops, and the development of data-sharing platforms 📊 that enhance research transparency and accessibility. Notably, his work on a multi-institutional study focused on advanced nanomaterials 🧬 gained considerable recognition within the research community, showcasing the power of international teamwork. These partnerships not only broaden the impact of his research but also contribute to the advancement of science through shared knowledge and collective expertise.

Professional Memberships

Mr. Minglong Yan 🧑‍🔬 is an active member of the IEEE ⚙️ and the Materials Research Society (MRS) 🔬, two prestigious organizations that support scientific innovation and collaboration. Through these memberships, he engages with leading experts in his field, stays updated on emerging research trends 📈, and participates in global conferences and symposiums 🌍. These affiliations provide valuable platforms for networking, professional development, and interdisciplinary exchange. Mr. Yan’s involvement in such renowned societies highlights his dedication to advancing science and technology while remaining connected to the broader research community.

Research Focus

Mr. Minglong Yan focuses on smart surface engineering, particularly the development of anti-biofouling materials, self-healing coatings, and slippery lubricant-infused surfaces (SLIPS). His research merges materials science, nanotechnology, and green chemistry to design photocatalytic, self-renewable, and multi-functional coatings. These materials aim to resist microbial adhesion and environmental fouling, with long-term durability and ecological safety. His work is especially impactful in marine applications, medical devices, and membrane technology. 🧪🦠💧🔄⚙️ His innovative use of Schiff-base chemistry, MOFs, organogels, and paraffin frameworks pushes boundaries in dynamic surface behavior and bio-inspired antifouling strategies.

Publication Top Notes

Designing a photocatalytic and self-renewed g-C3N4 nanosheet/poly-Schiff base composite coating towards long-term biofouling resistance

Cinnamaldehyde grafted porous Aerogel-Organ gel liquid infused surface for achieving difunctional long-term dynamic antifouling

Multi-stimulus Response Behavior of Biomimetic Autocrine Waxy Materials for Potential Self-Constructing Surface Microstructures

Antibacterial-renew dual-function anti-biofouling strategy: Self-assembled Schiff-base metal complex coatings built from natural products

Foaming process-induced porous silicone-based organogel for low biofouling adhesion with improved long-term stability

Cross‐Linked but Self‐Healing and Entirely Degradable Poly‐Schiff Base Metal Complex Materials for Potential Anti‐Biofouling

Designing a MOF-based slippery lubricant-infused porous surface with dual functional anti-fouling strategy

Yu Liu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Yu Liu | Drug Discovery and Development | Best Researcher Award

Mr. Yu Liu, China Institute of Pharmaceutical Industry Co., Ltd, China

Dr. Liu Yu (b. January 11, 1981, Hengyang, Hunan) is a distinguished researcher and doctoral supervisor specializing in medicinal chemistry. He earned his Ph.D. from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2011). Currently, he serves as Deputy Director at the China National Institute for the Control of Pharmaceutical and Biological Products and the Shanghai Drug Synthesis Process Engineering Technology Research Center. He is also a standing committee member of the Health Economics Theory and Policy Committee. Dr. Liu plays a pivotal role in pharmaceutical research and technology transfer in China.

Publication Profile

Scopus

Education

Mr. Yu Liu pursued his education in Medicinal Chemistry 🧪 at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences 🎓. He was enrolled as a full-time student from September 2008 to July 2011 📅. During this period, he dedicated himself to advanced research in the field, ultimately earning a Doctorate degree 🎖️. His studies focused on the development of medicinal compounds and pharmaceutical innovations, contributing to the field of drug discovery and development 💊. With a strong academic foundation, Mr. Liu gained expertise in chemical synthesis and pharmacology, preparing him for a successful career in medicinal sciences 🔬.

Professional Leadership

Mr. Yu Liu serves as the Deputy Director 🏛️ at both the Technology Transfer Center, China National Institute for the Control of Pharmaceutical and Biological Products and the Shanghai Drug Synthesis Process Engineering Technology Research Center 🔬. In these roles, he plays a pivotal part in advancing pharmaceutical and biotechnology research 💊. His leadership drives innovation in drug development and synthesis, ensuring progress in the field of medicinal chemistry 🧪. With his extensive expertise, Mr. Liu significantly contributes to technology transfer, regulatory advancements, and pharmaceutical innovation, reinforcing his influence in the global healthcare industry 🌍.

Experience

Mr. Yu Liu is an esteemed member of high-level academic committees 🏛️, including the Standing Committee of the Health Economics Theory and Policy Professional Committee under the Chinese Association of Health Economics 📊. His active participation in these organizations reflects his dedication to bridging scientific innovation and economic policy in healthcare 💡💰. By contributing to policy development and strategic decision-making, he plays a crucial role in shaping the future of health economics and pharmaceutical advancements 💊. His interdisciplinary expertise ensures a significant impact on both scientific research and economic frameworks, fostering innovation in healthcare systems 🌍.

Research Focus

Yu Liu’s research focuses on analytical chemistry, particularly in pharmaceutical analysis. His expertise lies in the development and validation of advanced chromatographic techniques, such as GC (Gas Chromatography) and HPLC-RID (High-Performance Liquid Chromatography with Refractive Index Detection). His work involves identifying and quantifying related substances in pharmaceutical compounds, including novel impurities in tetrabenazine. His contributions ensure drug purity, safety, and efficacy, making a significant impact on quality control and regulatory compliance in the pharmaceutical industry. His research bridges analytical chemistry and pharmaceutical sciences, advancing drug formulation and safety.

Publication Top Notes

GC and HPLC-RID method development and validation for the determination of twelve related substances, including several novel compounds in tetrabenazine

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Mr. Bekri Melka Abdo, Ethiopian Institute of Agricultural Research, Ethiopia

Bekri Melka Abdo is a dedicated organic chemist specializing in natural product chemistry 🌿. With expertise in plant sample collection, extraction, compound isolation, and structure elucidation, he focuses on bioactive compounds from Ethiopia’s medicinal and aromatic plants. His research contributes to developing natural product-based treatments for leishmaniasis 🦠. He has two published journal articles, an h-index of 7, a Google patent, and an ISBN-registered book 📖. Actively engaged in research and consultancy, Bekri is committed to innovative drug discovery and advancing natural product chemistry for global health.

Publication Profile

orcid

Education

Bekri Melka Abdo is a dedicated professional in organic chemistry 🧪, specializing in natural product chemistry 🌿. His expertise encompasses plant sample collection and preparation, extraction, compound isolation, and structure elucidation. He is skilled in qualitative and quantitative analysis, as well as biological activity determination of natural products extracted from various aromatic and medicinally significant 🌱 exotic and endemic plant species of Ethiopia. With a strong foundation in the field, he contributes to the discovery and characterization of bioactive compounds, supporting advancements in medicine, pharmaceuticals, and biotechnology 🔬. His research plays a vital role in exploring Ethiopia’s rich botanical resources.

Experience 

Bekri Melka Abdo is a passionate researcher in natural product chemistry 🌿, with a strong track record of research and innovation 🔬. He has successfully completed two research projects and maintains an h-index of 7 📊. His contributions extend to industry consultancy and collaborative projects, showcasing his impact in the field. He has authored a book with an ISBN 📖 and has a Google patent pending. His work is recognized in SCI and Scopus-indexed journals 🏅, with two publications. Actively engaged in editorial roles and professional memberships, he continues to drive scientific advancements in bioactive compound discovery.

Award

Bekri Melka Abdo, with his early career achievements and promising research in natural product chemistry 🌿, is an ideal candidate for the Young Scientist Award 🏆. His dedication to bioactive compound discovery, coupled with his impactful contributions to scientific research and innovation 🔬, highlights his potential for future breakthroughs. With a strong foundation in natural product extraction, analysis, and biological activity determination, he is paving the way for new discoveries in medicine and biotechnology 💊. This award category recognizes emerging researchers like Mr. Abdo, whose work demonstrates both excellence and the promise of transformative scientific advancements.

Research Focus

Mr. Bekri Melka Abdo specializes in phytochemistry and antiparasitic drug discovery, focusing on the bioassay-guided isolation of natural compounds for therapeutic applications. His research on dehydrocostus lactone from Echinops kebericho highlights its potential as a leishmanicidal drug 🦟⚕️. His work integrates natural product chemistry, pharmacognosy, and infectious disease research, contributing to novel drug development against leishmaniasis. By combining traditional medicinal plants with modern bioassays, he advances the search for effective, plant-derived antiparasitic treatments 🌱🔬. His research holds promise for addressing neglected tropical diseases through sustainable and nature-inspired therapies.

Publication Top Notes

Bioassay-guided isolation of dehydrocostus lactone from Echinops kebericho as a leishmanicidal drug

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Published on by Top Pharmaceutical

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Dr. Awatef Sassi, Faculty of medicine of sousse, Tunisia

Dr. Awatef Sassi 🧬🔬 is a distinguished postdoctoral researcher at the Faculty of Medicine of Sousse, specializing in cardiovascular and metabolic research. She earned her Ph.D. in Biological Sciences (2018) from the Faculty of Science of Bizerte, following a Master’s in Vascular Diseases Biology (2011) and a Medical Biotechnology degree (2008). Dr. Sassi has contributed significantly to scientific advancements, securing a patent on anti-hypertensive properties of Rosmarinus officinalis and publishing in high-impact journals. She is actively involved in mentoring medical theses and conducting innovative research in biophysics and applied toxicology. 🌿📊

Publication Profile

Orcid

Education

Dr. Awatef Sassi is a distinguished scholar in biological sciences 🧬, biotechnology 🏥, and vascular diseases ❤️. With a Ph.D. in Biological Sciences 🎓, a Master’s in Vascular Disease Biology, and a Medical Biotechnology degree, she has demonstrated an unwavering commitment to scientific research 🔬. Her extensive expertise spans innovative biotechnological applications and advancements in vascular health, contributing significantly to the medical and scientific communities. Dr. Sassi’s dedication to excellence and groundbreaking research continues to shape the future of biotechnology and vascular medicine, making her a respected figure in the field 🌟.

Experience 

Dr. Awatef Sassi’s postdoctoral research at the Faculty of Medicine in Sousse 🏥 has focused on cardio-pulmonary interactions 💓💨 and biophysics ⚛️, making significant contributions to biomedical sciences. As a dedicated mentor, she has supervised multiple medical theses 📚, showcasing her leadership in academia. Her patented innovation 🏅 on the antihypertensive activity of Rosmarinus officinalis 🌿 (TN 2023/0143) highlights groundbreaking research with potential clinical impact in hypertension treatment 💊. Through her pioneering work, Dr. Sassi continues to advance medical science, bridging research and practical healthcare solutions for improved cardiovascular health ❤️.

Professional Development

Dr. Awatef Sassi is a dedicated educator and researcher 🎓🔬, with extensive experience as a lecturer in analytical chemistry ⚗️. Her involvement in postgraduate training 📚 has strengthened expertise in HPLC/UPLC 💉, mass spectrometry 🧪, and data analysis (SPSS) 📊. Through her teaching and mentorship, she equips students and researchers with essential analytical and computational skills, fostering scientific excellence. Dr. Sassi’s commitment to professional development ensures that future scientists gain hands-on experience in advanced laboratory techniques, making a lasting impact in biotechnology, pharmacology, and medical sciences 🏥🌿.

Research Focus

Dr. Awatef Sassi’s research primarily focuses on phytomedicine 🌿, clinical nutrition 🥗, cardiovascular health ❤️, and pharmaceutical sciences 💊. Her work explores the therapeutic potential of medicinal plants like Rosmarinus officinalis and Nitraria retusa for conditions such as hypertension, obesity, and lipid disorders. Additionally, she has contributed to cardiovascular interventions 🏥, dermatological formulations, and transfusion medicine 🩸. Her studies include randomized clinical trials, pilot studies, and formulation research, highlighting her interdisciplinary approach to natural product-based therapy and clinical pharmacology. Her work significantly impacts personalized medicine, preventive healthcare, and alternative treatment strategies.

Publication Top Notes

The Effect of Rosmarinus officinalis L Infusion Supplementation on Blood Pressure Among Healthy Volunteers and Grade 1 Hypertensive Patients

Antiobesity and Hypolipidemic Potential of Nitraria retusa Extract in Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults

Distal radial approach versus conventional radial approach: a comparative study of feasibility and safety

Formulation and evaluation of topical halofuginone gel using a novel <I>ex vivo</i> model

RHD genotyping and its implication in transfusion practice

Johan Alexander Villada Ramos | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Johan Alexander Villada Ramos | Drug Discovery and Development | Best Researcher Award

Prof. Johan Alexander Villada Ramos, Universidad del Quindío, Colombia

Johan Alexander Villada Ramos is a Ph.D. candidate in Sciences at Universidad del Quindío, specializing in natural alternatives to synthetic pesticides 🌱🦠. He holds a Master’s in Biomedical Sciences, earning a meritorious distinction 🏅, and a Biology degree. His research spans bioactive plant compounds, cancer prevention, and lipid metabolism. As a university lecturer 📚, he teaches molecular biology and biochemistry. With multiple research projects, publications, and awards, including the Carlos Corredor Pereira National Award in Biomedical Sciences (2024) 🏆, Johan is a dedicated scientist pushing the boundaries of biotechnology and microbiology.

Publication Profile

Orcid

Education

Prof. Johan Alexander Villada Ramos 🎓 is a doctoral student in Sciences at the Universidad del Quindío, focusing on the bioactivity of free and microencapsulated Tagetes erecta L. 🌿 as an alternative to synthetic pesticides against the avocado weevil Heilipus lauri 🥑. He earned a Master’s in Biomedical Sciences (2018–2022) with meritorious distinction 🏅, researching the effects of Passiflora edulis extract on lipid metabolism enzymes in human colorectal adenocarcinoma cells. His Biology degree (2013–2018) involved evaluating the antibacterial activity of Tagetes patula L. against Ralstonia solanacearum. Additionally, he trained in microbiology and biotechnology lab preparation at SENA (2017–2018) 🔬.

Professional Achievements

Prof. Johan Alexander Villada Ramos 🎓 has made significant contributions to biomedical and biological research. He earned a meritorious distinction 🏅 for his master’s research on Passiflora edulis 🍊 and its effects on lipid metabolism in colorectal cancer cells. Holding a Biology degree 🔬, his studies focused on the antimicrobial activity of plant extracts against pathogens. He has been actively involved in high-impact research projects 📚 at prestigious institutions, including Pontificia Universidad Javeriana and Universidad del Quindío. His work continues to advance natural alternatives 🌱 in disease management, reinforcing his dedication to scientific discovery and innovation.

Leadership in Academia

Prof. Johan Alexander Villada Ramos 🎓 is a dedicated academic leader, serving as a lecturer 📖 in molecular biology, biochemistry, and microbiology 🔬 at Universidad del Quindío. Passionate about education, he actively contributes to curriculum development 🏫, ensuring that students receive up-to-date and high-quality training. Additionally, he plays a key role in laboratory training 🧪, equipping future scientists with essential research skills. His commitment to fostering scientific knowledge and practical expertise strengthens the university’s academic foundation, inspiring students to excel in the fields of biotechnology, microbiology, and biomedical sciences. 🚀

Research Focus

Prof. Johan Alexander Villada Ramos specializes in natural product chemistry, biochemistry, and phytopharmacology, with a strong focus on the antioxidant, antibacterial, and anticancer properties of plant extracts. His research explores bioactive compounds from medicinal plants, such as Coffea arabica ☕, Passiflora edulis 🍃, and Tagetes patula 🌼, investigating their effects on oxidative stress, protein oxidation, and bacterial inhibition 🦠. His studies contribute to pharmaceutical development, food science, and biomedicine, aiming to harness plant-derived compounds for disease prevention and therapeutic applications. 🏥

Publication Top Notes

Potencial antioxidante del extracto de hoja de Coffea arabica sobre la lipoperoxidación y oxidación proteica en un modelo de músculo bovino

Identification of potential bioactive compounds of Passiflora edulis leaf extract against colon adenocarcinoma cells

Evaluation of antibacterial activity of extract and essential oil of Tagetes patula L. in vitro against Ralstonia solanacearum biovar 2

Tamara Shushpanova | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Tamara Shushpanova | Drug Discovery and Development | Best Researcher Award

Prof Tamara Shushpanova,Tomsk National Research Medical Center of Russian Academy of Science, Russia

🧠 Tamara Vladimirovna Shushpanova – a leading researcher at the Tomsk National Research Medical Center of the Russian Academy of Sciences, specializes in neurochemistry and neuropharmacology 🧪. Her research focuses on the benzodiazepine receptor system in addiction, studying ligand binding in alcohol dependence using molecular docking with GABAA receptor sites. She has authored 100+ scientific papers, holds 5 patents, and has contributed to major conferences (EPA, WPA, ECNP) 📚. With extensive work on innovative molecules Halodif and Halonal, her contributions drive advancements in psychiatry, pharmacology, and addiction medicine. 🎓🔬

Publication Profile

orcid

Education

Prof. Tamara Shushpanova is a dedicated researcher at the Laboratory of Neurobiology, Russian Academy of Sciences 🧠. Her work spans Neurochemistry, Clinical Pharmacology, Psychiatry, and Addiction Medicine 🏥. She has contributed significantly to understanding ethanol’s effects on the human brain and targeted therapies for correction. Notable publications include Molecular-Cellular Targets of the Pathogenetic Action of Ethanol in the Human Brain in Ontogenesis, Halonal: An Original Benzoylated Phenobarbital Derivative Anticonvulsant, and A Novel Urea Derivative Anticonvulsant 📖. Through her research, she advances treatments for neurological disorders, enhancing clinical applications and therapeutic strategies 🔬.

Professional Memberships

Prof. Tamara Shushpanova is an active member of several prestigious professional organizations in neuroscience and psychiatry 🌍. She is affiliated with the European Psychiatric Association (EPA), the World Psychiatric Association (WPA), and the European College of Neuropsychopharmacology (ECNP) 🏥. These memberships connect her with leading experts, enabling collaboration on cutting-edge research in neurochemistry, clinical pharmacology, and addiction medicine 🔬. Through these associations, she contributes to global discussions on mental health, pharmacological advancements, and innovative therapeutic strategies 🧠. Her involvement ensures she remains at the forefront of scientific progress, shaping the future of psychiatry and neurobiology 📚.

Academic Research

Prof. Tamara Shushpanova actively shares her research on ResearchGate 📚, where her contributions to neurochemistry, clinical pharmacology, and psychiatry are accessible to the global scientific community 🌍. Her profile serves as a platform for collaboration, knowledge exchange, and engagement with fellow researchers 🔬. Additionally, she provides links to relevant identification and certification documents, ensuring transparency and credibility in her academic and professional endeavors 🏅. By maintaining an active digital presence, she enhances the visibility of her work, fostering innovation and scientific progress in the field of neuroscience and pharmacology 🧠

Research Focus

Tamara Shushpanova is a distinguished researcher specializing in neuropharmacology 🧠💊, medicinal chemistry ⚗️, and molecular neuroscience 🔬. Her work primarily focuses on the development of novel anticonvulsants, particularly targeting GABAA receptors for conditions like epilepsy and alcohol withdrawal syndrome. She explores drug delivery systems 🚀, enantiomeric drug behavior 🔄, and neuroimmune interactions 🧬. Her research spans molecular docking, chemometric analysis, and in vivo pharmacological studies, contributing to innovative treatments for neurological disorders. Additionally, she investigates prenatal alcohol exposure 🍷🚼 and its impact on brain development, emphasizing glioblasts and neuronal receptor formation in neuroimmune regulation.

Publication Top Notes

Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers

Innovative Technology of the Self-Emulsifying Drug Delivery System of the Anticonvulsant Galodif

Synthesis and Properties of a Water-Soluble Ureide Derived from Gаlodif and Succinic Acid

A novel urea derivative anticonvulsant: In vivo biological evaluation, radioreceptor analysis of GABAA receptors and molecular docking studies of enantiomers

Effect of original anticonvulsant ortho-fluoro-benzonal on immune cells functional properties at chronic ethanol intoxication

The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin

EMBRIOGENESIS OF NEURONAL ELENENTS (GLIOBLASTS AND GABAA RECEPTORS) IN THE HUMAN BRAIN NEUROIMMUNE SYSTEM UNDER PRENATAL ALCOHOL EXPOSURE

An Innovatory GABA Receptor Modulator and Liver Oxidase System Microsomal Cytochrome P450 Activator in Patients with Alcoholism

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Published on by Top Pharmaceutical

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao 🧪🔬 is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. 📚🔍 His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Scopus

Education

Dr. Hui Xiao 🎓 holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏢, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. 🔬

Professional Impact

Dr. Hui Xiao 🎓 is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏢, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization 🔬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. 🚀

Scientific Contributions

Dr. Hui Xiao 🎓 is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis 🔬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development 💊. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. 🚀

Potential Considerations

Dr. Hui Xiao 🎓 is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization 🔬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award 🏆 may prioritize direct advancements in drug discovery and novel pharmaceutical interventions 💊. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. 🚀

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry 🧪, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques ⚖️. His work involves CRISPR sgRNA modification analysis 🧬🔬 and the development of LC-MS-based assays for biological therapeutics 💊. He specializes in phosphorothioate isomer detection 🔄 and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) 📊 for precise biomolecular quantification. His contributions are crucial in drug discovery 🏥, gene editing 🧬, and biopharmaceutical development 💉. His expertise bridges biotechnology 🔬 and analytical methodologies 📈, advancing innovations in therapeutic monitoring and molecular diagnostics 🏥.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum

Tang Jin-Bao | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Tang Jin-Bao | Pharmacology | Best Researcher Award

Prof. Dr Tang Jin-Bao,Shandong Second Medical University,China

Prof. Dr. Jin-Bao Tang, a licensed pharmacist in China, is a professor at Shandong Second Medical University. He earned his Ph.D. in Microbial and Biochemical Pharmacy from Shandong University in 2023. An esteemed graduate sponsor in Shandong Province, he specializes in Biotechnological Pharmaceutics and Pharmaceutical Engineering. His research focuses on developing novel immunoassay biosensors for proteins and peptides. With multiple high-impact publications in Food Chemistry and Analytical Bioanalytical Chemistry, he has pioneered advanced immunosensor technologies. His innovative contributions to biosensor development enhance precision in food safety and biomedical analysis. 🔬📚

Publication Profile

Scopus

Education

Prof. Dr. Jin-Bao Tang 🎓 holds a Doctorate in Microbial and Biochemical Pharmacy from Shandong University (2023) and is a licensed pharmacist in China. As a distinguished professor at Shandong Second Medical University, he plays a vital role in educating future pharmaceutical professionals in Biotechnological Pharmaceutics and Pharmaceutics Engineering 🧪. His dedication to academia is evident through his mentorship and contributions to pharmaceutical sciences. Recognized as an excellent graduate sponsor of Shandong Province 🏆, Dr. Tang’s expertise and commitment continue to shape the next generation of researchers and industry leaders in the field of pharmacy. 💊

Scientific Community

Prof. Dr. Jin-Bao Tang 🧑‍🔬 has made a significant impact in the scientific community through his groundbreaking research in biotechnology and pharmacology. His publications appear in prestigious journals such as Food Chemistry, International Journal of Biological Macromolecules, Food Control, and Analytical Bioanalytical Chemistry 📚. His collaborative work has led to advancements in oriented antibody immobilization, photoconjugation strategies, and biosensor technology 🧪, with profound implications for public health, biotechnology, and pharmacological applications. Through his innovative contributions, Prof. Tang continues to shape the future of pharmaceutical sciences, enhancing diagnostic and therapeutic approaches for global healthcare. 🌍💊

Research Contributions

Prof. Dr. Tang Jin-Bao’s research revolves around developing novel immunoassay biosensors for protein and peptide detection 🧪🔬. His pioneering work has significantly advanced biosensing technology, particularly in food safety and biomedical analysis 🍎⚕️. Over the past five years, his high-impact publications have introduced innovative techniques such as electrochemical immunosensors for aflatoxin detection ⚡, bioluminescent immunoassays using antibody-nanoluciferase conjugates ✨, and Fc-specific antibody modifications for enhanced biosensor performance 🧫. Additionally, his photoconjugation strategies have led to stable fluorescent antibody fabrication 🌟. These breakthroughs contribute immensely to food safety, pharmaceutical analysis, and immunodiagnostics, demonstrating the real-world impact of his research. 🚀

Research Focus

Prof. Dr. Jin-Bao Tang’s research primarily focuses on biosensors 🧪, immunoassays 🏥, and antibody engineering 🧬 for food safety and biomedical applications. His work involves developing electrochemical immunosensors ⚡, bioluminescent assays 💡, and advanced antibody modifications 🏗️ to enhance the detection of harmful contaminants like aflatoxin B1 🍄⚠️. He explores oriented antibody immobilization 🎯 to improve sensitivity and specificity in bioanalytical methods. Additionally, his research extends to drug delivery systems 💊, particularly in pulsatile release formulations ⏳, using innovative polymers. His contributions advance food safety 🥗, biomedical diagnostics 🏥, and pharmaceutical technologies 💊 for global health and safety.

Publication Top Notes

A facile and effective electrochemical immunosensor based on controlled and oriented immobilization of natural antibodies for sensitive detection of aflatoxin B1

Development of a bioluminescent immunoassay based on Fc-specific conjugated antibody–nanoluciferase immunoreagents for determining aflatoxin B1

Fabrication of cysteine-modified antibodies with Fc-specific conjugation for covalent and oriented immobilization of native antibodies

Preparation of enteric capsules with pulsatile drug delivery potential using pullulan and polyacrylic acid resin III